<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Radiopharmaceutical supply disruptions and the use of Tc-99m-hydroxymethylene diphosphonate as an alternative to Tc-99m-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis

An ASNC Information Statement

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 2022 Netherlands Publisher:Elsevier BVJournal:Journal of Nuclear Cardiology, volume 29, pages 2,748-2,760 (issn: 1071-3581,

Authors: Miller, Edward J.; Campisi, Roxana; Shah, Nishant R.; McMahon, Sean; Cuddy, Sarah; Gallegos-Kattan, Cesia; Maurer, Mathew S.; +4 Authors

doi: 10.1007/s12350-022-03059-5 , 10.5281/zenodo.6687333 , 10.5281/zenodo.6722118

pmid: 35838892

pmc: PMC9285188

handle: 11370/6da73f36-b42e-41a9-93f8-8c5928ecc738

Radiopharmaceutical supply disruptions and the use of Tc-99m-hydroxymethylene diphosphonate as an alternative to Tc-99m-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis

- Summary
- Subjects
- Related research
  (2)
- Metrics

Abstract

Amid pyrophosphate shortage, the American Society of Nuclear Cardiology issues an information statement on how to use HMDP as an alternative radiopharmaceutical in cardiac amyloidosis imaging. Early diagnosis of ATTR cardiac amyloidosis must not be jeopardized.

Country

Netherlands

Related Organizations

Yale University
United States
Brigham and Women's Faulkner Hospital
United States
Brown University
United States
Instituto Argentino de Diagnóstico y Tratamiento
Argentina
University of Paris
France

View all View all

Keywords

Technetium Tc 99m Pyrophosphate, Diphosphonates, Information Statement, HMDP, hydroxymethylene diphosphonate, PYP, pyrophosphate, cardiac amyloidosis, Radiopharmaceutical, supply disruption, PYP shortage, Tc-99m-hydroxymethylene diphosphonate, Amyloidosis, radiopharmaceutical supply, transthyretin cardiac amyloidosis, Diphosphates, Humans, Prealbumin, ETIOLOGIC DIAGNOSIS, SCINTIGRAPHY, Radiopharmaceuticals, Cardiomyopathies

Filter by relation

All relations

arrow_drop_down

2 Research products, page 1 of 1

Radiopharmaceutical Supply Disruptions and the Use of 99mTc-99 Hydroxymethylene Diphosphonate as an Alternative to 99mTc-Pyrophosphate for the Diagnosis of Transthyretin Cardiac Amyloidosis: An ASNC Information Statement
descriptionPublication2022HasVersion
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Radiopharmaceutical Supply Disruptions and the Use of 99mTc-99 Hydroxymethylene Diphosphonate as an Alternative to 99mTc-Pyrophosphate for the Diagnosis of Transthyretin Cardiac Amyloidosis: An ASNC Information Statement
descriptionPublication2022IsAmongTopNSimilarDocuments
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
citeCite
addClaim
Please grant OpenAIRE to access and update your ORCID works.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
This Research product is the result of merged Research products in OpenAIRE.

You have already added works in your ORCID record related to the merged Research product.
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	8
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%